Study 1 of 22Tesofensine literatureSemanticScholar2010
Semantic Scholar search for Tesofensine
Not reported in abstract.
Where it sits
this study against the rest of the tesofensine corpus7
Preclinical · this one
14
Observational
0
Open-label
1
Randomised
0
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.
Elsewhere in the Tesofensine corpus
CEnsemble Docking, MD, and MM/PBSA Identify Flavonoids as Putative Modulators of EFNB2/B3-Nipah Virus G Interaction.International journal of molecular sciences · 2026 · Not reported in abstract.In vitroCA tomato MIK2-clade receptor is involved in the perception of a Fusarium-derived elicitor.The New phytologist · 2026 · Not reported in abstract.In vitroBLong COVID symptom profiles, workforce participation, and working hours among adults in England: a population-based cohort study.The Lancet regional health. Europe · 2026 · Adjusted odds ratio [aOR]: 0.62, 95% CI: 0.55, 0.70 for being in paid work with unresolved Long COVID.HumanCOccurrence of Phenotypic Multidrug-Resistant <i>E. coli</i> in Kentucky (USA) Surface Waters and Exploration of Sentinel Antibiotics for One Health Surveillance.Antibiotics (Basel, Switzerland) · 2026 · 100% TE non-susceptibility in E. coli from TE-treated media.AnimalDMDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights.Movement disorders clinical practice · 2026 · SPRS scores increased with increasing age at examination after the age of 40 years.reviewCDesign and computational evaluation of <i>E</i>-stilbene-bearing 1,3,4-oxadiazole derivatives as potential tyrosinase inhibitors using DFT, molecular docking and ADMET studies.RSC advances · 2026 · IC50 values of 0.32 ± 0.03 µM and 0.76 ± 0.01 µM for compounds 5d and 5b, respectively.In vitro